EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document E2008C0612(02)
Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the second half of 2007
Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the second half of 2007
Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the second half of 2007
OJ C 146, 12.6.2008, p. 13–23
(BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
12.6.2008 |
EN |
Official Journal of the European Union |
C 146/13 |
Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the second half of 2007
(2008/C 146/03)
Subcommittee I — On the free movement of goods
To be noted by the EEA Joint Committee
With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 July-31 December 2007, at their meeting on 14 March 2008:
|
Annex I |
List of new marketing authorisations |
|
Annex II |
List of renewed marketing authorisations |
|
Annex III |
List of extended marketing authorisations |
|
Annex IV |
List of withdrawn marketing authorisations |
|
Annex V |
List of suspended marketing authorisations |
ANNEX I
List of new marketing authorisations
The following marketing authorisations have been granted in the EEA EFTA States during the period 1 July-31 December 2007:
|
EU Number |
Product |
Country |
Date of authorisation |
|
EU/1/06/361/001 |
Luminity |
Liechtenstein |
31.12.2007 |
|
EU/1/07/387/001-008 |
Advagraf |
Liechtenstein |
31.12.2007 |
|
EU/1/07/391/001/NO-004/NO |
Revlimid |
Norway |
13.7.2007 |
|
EU/1/07/391/001-004/IS |
Revlimid |
Iceland |
11.7.2007 |
|
EU/1/07/392/001 |
Circadin |
Liechtenstein |
31.8.2007 |
|
EU/1/07/392/001/IS |
Circadin |
Iceland |
8.8.2007 |
|
EU/1/07/392/001/NO |
Circadin |
Norway |
15.8.2007 |
|
EU/1/07/393/001/IS |
Soliris |
Iceland |
19.7.2007 |
|
EU/1/07/393/001/NO |
Soliris |
Norway |
19.7.2007 |
|
EU/1/07/394/001/NO-006/NO |
Optaflu |
Norway |
20.8.2007 |
|
EU/1/07/395/001/NO-064/NO |
Invega |
Norway |
17.7.2007 |
|
EU/1/07/395/001-064 |
Invega |
Liechtenstein |
31.8.2007 |
|
EU/1/07/395/001-064/IS |
Invega |
Iceland |
20.7.2007 |
|
EU/1/07/396/001/NO-003/NO |
Pergoveris |
Norway |
3.7.2007 |
|
EU/1/07/396/001-003 |
Pergoveris |
Liechtenstein |
31.8.2007 |
|
EU/1/07/396/001-003/IS |
Pergoveris |
Iceland |
20.7.2007 |
|
EU/1/07/397/001 |
Siklos |
Liechtenstein |
31.8.2007 |
|
EU/1/07/397/001/IS |
Siklos |
Iceland |
19.7.2007 |
|
EU/1/07/397/001/NO |
Siklos |
Norway |
22.8.2007 |
|
EU/1/07/398/001/NO-014/NO |
Optimark |
Norway |
20.8.2007 |
|
EU/1/07/398/001-014 |
OptiMark |
Liechtenstein |
31.8.2007 |
|
EU/1/07/398/001-014/IS |
OptiMark |
Iceland |
20.8.2007 |
|
EU/1/07/399/001/NO-006/NO |
Aerinaze |
Norway |
22.8.2007 |
|
EU/1/07/399/001-006 |
Aerinaze |
Liechtenstein |
31.8.2007 |
|
EU/1/07/399/001-006/IS |
Aerinaze |
Iceland |
30.8.2007 |
|
EU/1/07/400/001/NO-016/NO |
Mircera |
Norway |
3.9.2007 |
|
EU/1/07/400/001-016/IS |
Mircera |
Iceland |
17.8.2007 |
|
EU/1/07/401/001/NO-006/NO |
Orlistat GSK |
Norway |
20.8.2007 |
|
EU/1/07/401/001-006 |
Orlistat GSK |
Liechtenstein |
31.8.2007 |
|
EU/1/07/401/001-006/IS |
Orlistat GSK |
Iceland |
21.8.2007 |
|
EU/1/07/402/001 |
Increlex |
Liechtenstein |
31.8.2007 |
|
EU/1/07/402/001/IS |
Increlex |
Iceland |
31.8.2007 |
|
EU/1/07/403/001 |
Atriance |
Liechtenstein |
31.10.2007 |
|
EU/1/07/403/001/IS |
Atriance |
Iceland |
20.9.2007 |
|
EU/1/07/403/001/NO |
Atriance |
Norway |
4.9.2007 |
|
EU/1/07/404/001/NO-005/NO |
Flebogammadif |
Norway |
13.9.2007 |
|
EU/1/07/404/001-005 |
Flebogammadif |
Liechtenstein |
31.10.2007 |
|
EU/1/07/404/001-005/IS |
Flebogammadif |
Iceland |
13.9.2007 |
|
EU/1/07/405/001/NO-020/NO |
Rasilez |
Norway |
14.9.2007 |
|
EU/1/07/405/001-020 |
Rasilez |
Liechtenstein |
31.10.2007 |
|
EU/1/07/405/001-020/IS |
Rasilez |
Iceland |
6.9.2007 |
|
EU/1/07/406/001/NO-020/NO |
Enviage |
Norway |
14.9.2007 |
|
EU/1/07/406/001-020 |
Enviage |
Liechtenstein |
31.10.2007 |
|
EU/1/07/406/001-020/IS |
Enviage |
Iceland |
11.9.2007 |
|
EU/1/07/407/001/NO-020/NO |
Sprimeo |
Norway |
14.9.2007 |
|
EU/1/07/407/001-020 |
Sprimeo |
Liechtenstein |
31.10.2007 |
|
EU/1/07/407/001-020/IS |
Sprimeo |
Iceland |
11.9.2007 |
|
EU/1/07/408/001/NO-020/NO |
Tekturna |
Norway |
14.9.2007 |
|
EU/1/07/408/001-020 |
Tekturna |
Liechtenstein |
31.10.2007 |
|
EU/1/07/408/001-020/IS |
Tekturna |
Iceland |
6.9.2007 |
|
EU/1/07/409/001/NO-020/NO |
Riprazo |
Norway |
14.9.2007 |
|
EU/1/07/409/001-020 |
Riprazo |
Liechtenstein |
31.10.2007 |
|
EU/1/07/409/001-020/IS |
Riprazo |
Iceland |
11.9.2007 |
|
EU/1/07/410/001/NO-016/NO |
Binocrit |
Norway |
13.9.2007 |
|
EU/1/07/410/001-016 |
Binocrit |
Liechtenstein |
31.10.2007 |
|
EU/1/07/410/001-016/IS |
Binocrit |
Iceland |
18.9.2007 |
|
EU/1/07/411/001/NO-016/NO |
Epoetin alfa Hexal |
Norway |
13.9.2007 |
|
EU/1/07/411/001-016 |
Epoetin alfa Hexal |
Liechtenstein |
31.10.2007 |
|
EU/1/07/411/001-016/IS |
Epoetin alfa Hexal |
Iceland |
19.9.2007 |
|
EU/1/07/412/001/NO-016/NO |
Abseamed |
Norway |
12.9.2007 |
|
EU/1/07/412/001-016 |
Abseamed |
Liechtenstein |
31.10.2007 |
|
EU/1/07/412/001-016/IS |
Abseamed |
Iceland |
19.9.2007 |
|
EU/1/07/413/001/NO-003/NO |
Gliolan |
Norway |
28.9.2007 |
|
EU/1/07/413/001-003 |
Gliolan |
Liechtenstein |
31.10.2007 |
|
EU/1/07/413/001-003/IS |
Gliolan |
Iceland |
21.9.2007 |
|
EU/1/07/414/001/NO-017/NO |
Galvus |
Norway |
8.10.2007 |
|
EU/1/07/414/001-017 |
Galvus |
Liechtenstein |
31.10.2007 |
|
EU/1/07/414/001-017/IS |
Galvus |
Iceland |
18.10.2007 |
|
EU/1/07/415/001/NO-056/NO |
Zalasta |
Norway |
16.10.2007 |
|
EU/1/07/415/001-056/IS |
Zalasta |
Iceland |
26.10.2007 |
|
EU/1/07/415/001-056 |
Zalasta |
Liechtenstein |
31.10.2007 |
|
EU/1/07/416/001 |
Ecalta |
Liechtenstein |
31.10.2007 |
|
EU/1/07/416/001/IS |
Ecalta |
Iceland |
13.10.2007 |
|
EU/1/07/416/001/NO |
Ecalta |
Norway |
28.9.2007 |
|
EU/1/07/417/001/NO-002/NO |
Yondelis |
Norway |
23.10.2007 |
|
EU/1/07/417/001-002 |
Yondelis |
Liechtenstein |
31.10.2007 |
|
EU/1/07/417/001-002/IS |
Yondelis |
Iceland |
15.10.2007 |
|
EU/1/07/418/001/NO-010/NO |
Celsentri |
Norway |
25.9.2007 |
|
EU/1/07/418/001-010 |
Celsentri |
Liechtenstein |
31.10.2007 |
|
EU/1/07/418/001-010/IS |
Celsentri |
Iceland |
13.10.2007 |
|
EU/1/07/419/001/NO-009/NO |
Cervarix |
Norway |
25.9.2007 |
|
EU/1/07/419/001-009 |
Cervarix |
Liechtenstein |
31.10.2007 |
|
EU/1/07/419/001-009/IS |
Cervarix |
Iceland |
12.10.2007 |
|
EU/1/07/420/001 |
Cyanokit |
Liechtenstein |
31.12.2007 |
|
EU/1/07/420/001/IS |
Cyanokit |
Iceland |
17.12.2007 |
|
EU/1/07/420/001/NO |
Cyanokit |
Norway |
19.12.2007 |
|
EU/1/07/421/001/NO-009/NO |
Pioglitazon/metformin Takeda |
Norway |
19.12.2007 |
|
EU/1/07/421/001-009 |
Pioglitazone/Metformin Hydrochloride Takeda |
Liechtenstein |
31.12.2007 |
|
EU/1/07/422/001-004/IS |
Tasigna |
Iceland |
14.12.2007 |
|
EU/1/07/424/001 |
Torisel |
Liechtenstein |
31.12.2007 |
|
EU/1/07/424/001/IS |
Torisel |
Iceland |
10.12.2007 |
|
EU/1/07/424/001/NO |
Torisel |
Norway |
3.12.2007 |
|
EU/1/07/425/001/NO-018/NO |
Eucreas |
Norway |
5.12.2007 |
|
EU/1/07/425/001-018 |
Eucreas |
Liechtenstein |
31.12.2007 |
|
EU/1/07/425/001-018/IS |
Eucreas |
Iceland |
6.12.2007 |
|
EU/1/07/426/001/NO-011/NO |
Olanzapine Neopharma |
Norway |
19.12.2007 |
|
EU/1/07/426/001-011/IS |
Olanzapine Neopharma |
Iceland |
7.12.2007 |
|
EU/1/07/426/001-011 |
Olanzapine Neopharma |
Liechtenstein |
31.12.2007 |
|
EU/1/07/433/001 |
Nevanac |
Liechtenstein |
31.12.2007 |
|
EU/1/07/433/001/NO |
Nevanac |
Norway |
18.12.2007 |
|
EU/107/427/001-037 |
Olanzapine Teva |
Liechtenstein |
31.12.2007 |
|
EU/2/06/067/001-002 |
Medicinal Oxygen Air Liquide Santé |
Liechtenstein |
31.12.2007 |
|
EU/2/06/070/001-003/IS |
Meloxidyl |
Iceland |
17.8.2007 |
|
EU/2/07/072/001/NO-002/NO |
Suprelorin |
Norway |
24.10.2007 |
|
EU/2/07/072/001-002 |
Suprelorin |
Liechtenstein |
31.8.2007 |
|
EU/2/07/072/001-002/IS |
Suprelorin |
Iceland |
10.8.2007 |
|
EU/2/07/074/001/NO-006/NO |
Prilactone |
Norway |
20.12.2007 |
|
EU/2/07/074/001-006/IS |
Prilactone |
Iceland |
19.7.2007 |
|
EU/2/07/075/001/NO-004/NO |
Circovac |
Norway |
20.12.2007 |
|
EU/2/07/075/001-004 |
Circovac |
Liechtenstein |
31.8.2007 |
|
EU/2/07/075/001-004/IS |
Circovac |
Iceland |
12.7.2007 |
|
EU/2/07/077/001-005 |
Meloxivet |
Liechtenstein |
31.12.2007 |
ANNEX II
List of renewed marketing authorisations
The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 July-31 December 2007:
|
EU Number |
Product |
Country |
Date of authorisation |
|
EU/1/02/209/001/NO-008/NO |
Dynastat |
Norway |
14.9.2007 |
|
EU/1/02/216/001/NO-002/NO |
Invanz |
Norway |
4.7.2007 |
|
EU/1/02/218/001/NO-011/NO |
Axura |
Norway |
16.7.2007 |
|
EU/1/02/218/001-011/IS |
Axura |
Iceland |
11.7.2007 |
|
EU/1/02/219/001/NO-015/NO |
Ebixa |
Norway |
11.7.2007 |
|
EU/1/02/219/001-015/IS |
Ebixa |
Iceland |
6.7.2007 |
|
EU/1/02/220/001/NO-005/NO |
Tracleer |
Norway |
13.8.2007 |
|
EU/1/02/221/001/NO-010/NO |
Pegasys |
Norway |
18.7.2007 |
|
EU/1/02/221/001-010/IS |
Pegasys |
Iceland |
13.7.2007 |
|
EU/1/02/221/001-010 |
Pegasys |
Liechtenstein |
31.8.2007 |
|
EU/1/02/222/001/NO-002/NO |
Tamiflu |
Norway |
31.7.2007 |
|
EU/1/02/222/001-002 |
Tamiflu |
Liechtenstein |
31.8.2007 |
|
EU/1/02/222/001-004/IS |
Tamiflu |
Iceland |
13.7.2007 |
|
EU/1/02/223/001/NO-003/NO |
Evra |
Norway |
17.9.2007 |
|
EU/1/02/223/001-003 |
Evra |
Liechtenstein |
31.10.2007 |
|
EU/1/02/223/001-003/IS |
Evra |
Iceland |
1.10.2007 |
|
EU/1/02/224/001/NO-005/NO |
Ambirix |
Norway |
25.9.2007 |
|
EU/1/02/224/001-005 |
Ambirix |
Liechtenstein |
31.10.2007 |
|
EU/1/02/224/001-005/IS |
Ambirix |
Iceland |
1.10.2007 |
|
EU/1/02/225/001/NO-002/NO |
Xigris |
Norway |
27.8.2007 |
|
EU/1/02/225/001-002 |
Xigris |
Liechtenstein |
31.8.2007 |
|
EU/1/02/225/001-002/IS |
Xigris |
Iceland |
16.8.2007 |
|
EU/1/02/226/001 |
InductOs |
Liechtenstein |
31.10.2007 |
|
EU/1/02/226/001/IS |
InductOs |
Iceland |
17.9.2007 |
|
EU/1/02/226/001/NO |
InductOs |
Norway |
10.9.2007 |
|
EU/1/02/227/001/NO-003/NO |
Neulasta |
Norway |
27.8.2007 |
|
EU/1/02/227/001-003 |
Neulasta |
Liechtenstein |
31.8.2007 |
|
EU/1/02/227/001-003/IS |
Neulasta |
Iceland |
16.8.2007 |
|
EU/1/02/228/001-003/IS |
Neupopeg |
Iceland |
15.8.2007 |
|
EU/1/02/228/001/NO-003/NO |
Neupopeg |
Norway |
27.8.2007 |
|
EU/1/02/228/001-003 |
Neupopeg |
Liechtenstein |
31.8.2007 |
|
EU/1/02/229/001/NO-037/NO |
Actraphane |
Norway |
9.10.2007 |
|
EU/1/02/229/001-037 |
Actraphane |
Liechtenstein |
31.10.2007 |
|
EU/1/02/229/001-037/IS |
Actraphane |
Iceland |
15.10.2007 |
|
EU/1/02/230/001/NO-017/NO |
Actrapid |
Norway |
9.10.2007 |
|
EU/1/02/230/001-017 |
Actrapid |
Liechtenstein |
31.10.2007 |
|
EU/1/02/230/001-017/IS |
Actrapid |
Iceland |
15.10.2007 |
|
EU/1/02/231/001/NO-037/NO |
Mixtard |
Norway |
9.10.2007 |
|
EU/1/02/231/001-037 |
Mixtard |
Liechtenstein |
31.10.2007 |
|
EU/1/02/231/001-037/IS |
Mixtard |
Iceland |
16.10.2007 |
|
EU/1/02/232/001/NO-003/NO |
Velosulin |
Norway |
9.10.2007 |
|
EU/1/02/232/001-003 |
Velosulin |
Liechtenstein |
31.10.2007 |
|
EU/1/02/232/001-003/IS |
Velosulin |
Iceland |
15.10.2007 |
|
EU/1/02/233/001/NO-017/NO |
Insulatard |
Norway |
9.10.2007 |
|
EU/1/02/233/001-017 |
Insulatard |
Liechtenstein |
31.10.2007 |
|
EU/1/02/233/001-017/IS |
Insulatard |
Iceland |
16.10.2007 |
|
EU/1/02/234/001/NO-017/NO |
Protaphane |
Norway |
9.10.2007 |
|
EU/1/02/234/001-017 |
Protaphane |
Liechtenstein |
31.10.2007 |
|
EU/1/02/234/001-017/IS |
Protaphane |
Iceland |
15.10.2007 |
|
EU/1/02/237/001/NO-008/NO |
Cialis |
Norway |
15.10.2007 |
|
EU/1/02/237/001-008 |
Cialis |
Liechtenstein |
31.10.2007 |
|
EU/1/02/237/001-008/IS |
Cialis |
Iceland |
15.10.2007 |
|
EU/1/02/238/001 |
Zavesca |
Liechtenstein |
31.10.2007 |
|
EU/1/02/238/001/IS |
Zavesca |
Iceland |
1.10.2007 |
|
EU/1/02/238/001/NO |
Zavesca |
Norway |
17.9.2007 |
|
EU/1/02/240/001/NO-004/NO |
Somavert |
Norway |
26.9.2007 |
|
EU/1/02/240/001-004 |
Somavert |
Liechtenstein |
31.10.2007 |
|
EU/1/02/240/001-004/IS |
Somavert |
Iceland |
19.10.2007 |
|
EU/1/97/031/001/NO-003/NO, 019/NO-046/NO |
Neorecormon |
Norway |
17.7.2007 |
|
EU/1/97/031/001-003, 019-046 |
NeoRecormon |
Liechtenstein |
31.8.2007 |
|
EU/1/97/031/001-013, 019-024, 027-046/IS |
NeoRecormon |
Iceland |
11.7.2007 |
|
EU/1/97/032/001/NO |
LeukoScan |
Norway |
4.7.2007 |
|
EU/1/97/037/001/IS |
Vistide |
Iceland |
6.7.2007 |
|
EU/1/97/037/001/NO |
Vistide |
Norway |
13.9.2007 |
|
EU/1/97/039/001/NO-004/NO |
Cystagon |
Norway |
31.7.2007 |
|
EU/1/97/039/001-004 |
Cystagon |
Liechtenstein |
31.8.2007 |
|
EU/1/97/039/001-004/IS |
Cystagon |
Iceland |
11.7.2007 |
|
EU/1/97/040/001/NO-002/NO |
Teslascan |
Norway |
20.8.2007 |
|
EU/1/97/043/001/NO-003/NO |
Revasc |
Norway |
16.7.2007 |
|
EU/1/97/043/001-003 |
Revasc |
Liechtenstein |
31.8.2007 |
|
EU/1/97/043/001-003/IS |
Revasc |
Iceland |
11.7.2007 |
|
EU/1/97/046/001/NO-039/NO |
Aprovel |
Norway |
19.9.2007 |
|
EU/1/97/046/001-033 |
Aprovel |
Liechtenstein |
31.10.2007 |
|
EU/1/97/046/001-039/IS |
Aprovel |
Iceland |
18.9.2007 |
|
EU/1/97/047/001/NO-007/NO |
BeneFIX |
Norway |
11.9.2007 |
|
EU/1/97/047/001-007 |
Benefix |
Liechtenstein |
31.10.2007 |
|
EU/1/97/047/001-007/IS |
BeneFix |
Iceland |
31.8.2007 |
|
EU/1/97/049/001/NO-039/NO |
Karvea |
Norway |
20.9.2007 |
|
EU/1/97/049/001-033 |
Karvea |
Liechtenstein |
31.10.2007 |
|
EU/1/97/049/001-039/IS |
Karvea |
Iceland |
17.9.2007 |
|
EU/1/97/050/001/NO-006/NO, 009/NO-012/NO |
Sifrol |
Norway |
16.10.2007 |
|
EU/1/97/050/001-006, 009-012 |
Sifrol |
Liechtenstein |
31.10.2007 |
|
EU/1/97/050/001-006, 009-012/IS |
Sifrol |
Iceland |
15.10.2007 |
|
EU/1/97/051/001/NO-006/NO, 009/NO-012/NO |
Mirapexin |
Norway |
15.10.2007 |
|
EU/1/97/051/001-006, 009-012 |
Mirapexin |
Liechtenstein |
31.10.2007 |
|
EU/1/97/051/001-006, 009-012/IS |
Mirapexin |
Iceland |
15.10.2007 |
|
EU/1/97/053/001/NO-005/NO |
Cerezyme |
Norway |
9.10.2007 |
|
EU/1/97/053/001-005 |
Cerezyme |
Liechtenstein |
31.10.2007 |
|
EU/1/97/053/001-005/IS |
Cerezyme |
Iceland |
15.10.2007 |
|
EU/1/97/057/001 |
Quadramet |
Liechtenstein |
31.12.2007 |
|
EU/2/02/032/001/IS |
Vaxxitek HVT + IBD |
Iceland |
10.7.2007 |
|
EU/2/02/033/001/IS |
Dexdomitor |
Iceland |
17.8.2007 |
|
EU/2/02/034/001/IS |
Nobivac Bb cat |
Iceland |
19.10.2007 |
|
EU/2/02/035/001-007 |
SevoFlo |
Liechtenstein |
31.12.2007 |
|
EU/2/02/035/001-007/IS |
SevoFlo |
Iceland |
6.12.2007 |
|
EU/2/033/001 |
Dexdomitor |
Liechtenstein |
31.10.2007 |
|
EU/2/034/001 |
Nobivac Bb |
Liechtenstein |
31.10.2007 |
|
EU/2/97/001-009/IS |
Quadrisol |
Iceland |
10.12.2007 |
|
EU/2/97/004/001, EU/2/97/004/003-028 |
Metacam |
Liechtenstein |
31.12.2007 |
|
EU/2/97/004/001/NO, 003/NO-030/NO |
Metacam |
Norway |
17.12.2007 |
|
EU/2/97/005/001-009 |
Quadrisol |
Liechtenstein |
31.12.2007 |
|
EU/2/98/010/004-014, 017-018, 021-024/IS |
Econor |
Iceland |
8.11.2007 |
ANNEX III
List of extended marketing authorisations
The following marketing authorisations have been extended in the EEA EFTA States during the period 1 July-31 December 2007:
|
EU Number |
Product |
Country |
Date of extention |
|
EU/1/00/151/023-024 |
Glustin |
Liechtenstein |
31.10.2007 |
|
EU/1/01/197/003/NO-005/NO |
Foscan |
Norway |
8.11.2007 |
|
EU/1/01/197/003-005 |
Foscan |
Liechtenstein |
31.10.2007 |
|
EU/1/01/197/003-005/IS |
Foscan |
Iceland |
12.11.2007 |
|
EU/1/02/222/003/NO-004/NO |
Tamiflu |
Norway |
27.9.2007 |
|
EU/1/02/222/003-004 |
Tamiflu |
Liechtenstein |
31.10.2007 |
|
EU/1/02/222/003-004/IS |
Tamiflu |
Iceland |
15.10.2007 |
|
EU/1/02/237/006/NO-008/NO |
Cialis |
Norway |
3.7.2007 |
|
EU/1/02/237/006-008 |
Cialis |
Liechtenstein |
31.8.2007 |
|
EU/1/03/254/002 |
Busilvex |
Liechtenstein |
31.12.2007 |
|
EU/1/03/260/016-018 |
Stalevo |
Liechtenstein |
31.10.2007 |
|
EU/1/04/290/002 |
Alimta |
Liechtenstein |
31.12.2007 |
|
EU/1/04/290/002/IS |
Alimta |
Iceland |
15.11.2007 |
|
EU/1/04/296/009 |
Cymbalta |
Liechtenstein |
31.10.2007 |
|
EU/1/05/310/006/NO-009/NO |
Fosavance |
Norway |
8.11.2007 |
|
EU/1/05/310/006-009 |
Fosavance |
Liechtenstein |
31.12.2007 |
|
EU/1/05/310/006-009/IS |
Fosavance |
Iceland |
19.10.2007 |
|
EU/1/05/325/002 |
Macugen |
Liechtenstein |
31.12.2007 |
|
EU/1/06/332/004/NO-006/NO |
Omnitrope |
Norway |
10.9.2007 |
|
EU/1/06/332/007/NO-009/NO |
Omnitrope |
Norway |
8.11.2007 |
|
EU/1/06/332/007-009 |
Omnitrope |
Liechtenstein |
31.10.2007 |
|
EU/1/06/332/007-009/IS |
Omnitrope |
Iceland |
17.10.2007 |
|
EU/1/06/344/010-011 |
Acomplia |
Liechtenstein |
31.10.2007 |
|
EU/1/06/345/010-011 |
Zimulti |
Liechtenstein |
31.10.2007 |
|
EU/1/06/347/004-006 |
Sutent |
Liechtenstein |
31.12.2007 |
|
EU/1/06/361/002 |
Luminity |
Liechtenstein |
31.12.2007 |
|
EU/1/06/364/006/NO-009/NO |
Adrovance |
Norway |
14.11.2007 |
|
EU/1/06/364/006-009 |
Adrovance |
Liechtenstein |
31.10.2007 |
|
EU/1/06/364/006-009/IS |
Adrovance |
Iceland |
19.10.2007 |
|
EU/1/06/366/005-016 |
Tandemact |
Liechtenstein |
31.12.2007 |
|
EU/1/95/003/005-006 |
Betaferon |
Liechtenstein |
31.10.2007 |
|
EU/1/96/022/023-034 |
Zyprexa |
Liechtenstein |
31.8.2007 |
|
EU/1/97/033/004 |
Avonex |
Liechtenstein |
31.8.2007 |
|
EU/1/97/046/034-039 |
Aprovel |
Liechtenstein |
31.10.2007 |
|
EU/1/97/047/004/NO-007/NO |
BeneFIX |
Norway |
4.9.2007 |
|
EU/1/97/047/004-007 |
BenFix |
Liechtenstein |
31.8.2007 |
|
EU/1/97/047/007/IS |
Benefix |
Iceland |
31.8.2007 |
|
EU/1/97/049/034-039 |
Karvea |
Liechtenstein |
31.10.2007 |
|
EU/1/98/066/019/NO-026/NO |
Exelon |
Norway |
10.10.2007 |
|
EU/1/98/066/019-026 |
Exelon |
Liechtenstein |
31.10.2007 |
|
EU/1/98/066/019-026/IS |
Exelon |
Iceland |
17.10.2007 |
|
EU/1/98/069/007a, 007b |
Plavix |
Liechtenstein |
31.8.2007 |
|
EU/1/98/070/007a, 007b |
Iscover |
Liechtenstein |
31.8.2007 |
|
EU/1/98/085/029-034 |
Karvezide |
Liechtenstein |
31.10.2007 |
|
EU/1/98/086/029-034 |
CoAprovel |
Liechtenstein |
31.10.2007 |
|
EU/1/98/092/019/NO-026/NO |
Prometax |
Norway |
10.10.2007 |
|
EU/1/98/092/019-026 |
Prometax |
Liechtenstein |
31.10.2007 |
|
EU/1/98/092/019-026/IS |
Prometax |
Iceland |
18.10.2007 |
|
EU/1/99/108/002-003 |
Ferriprox |
Liechtenstein |
31.12.2007 |
|
EU/1/99/108/002/NO-003/NO |
Ferriprox |
Norway |
5.12.2007 |
|
EU/1/99/108/002-003/IS |
Ferriprox |
Iceland |
10.12.2007 |
|
EU/2/039/019-030 |
Advocate |
Liechtenstein |
31.8.2007 |
|
EU/2/97/004/029-030 |
Metacam |
Liechtenstein |
31.12.2007 |
ANNEX IV
List of withdrawn marketing authorisations
The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 July-31 December 2007:
|
EU Number |
Product |
Country |
Date of withdrawal |
|
EU/1/01/92/001-005 |
Levviax |
Liechtenstein |
31.12.2007 |
|
EU/1/03/257/001/NO-010/NO |
Trudexa |
Norway |
29.8.2007 |
|
EU/1/03/257/001-010 |
Trudexa |
Liechtenstein |
31.8.2007 |
|
EU/1/03/257/001-010/IS |
Trudexa |
Iceland |
9.8.2007 |
ANNEX V
List of suspended marketing authorisations
The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 July-31 December 2007:
|
EU Number |
Product |
Country |
Date of suspension |
|
EU/1/97/054/001, 003-005 |
Viracept |
Liechtenstein |
31.8.2007 (1) |
|
EU/1/97/054/001-005/IS |
Viracept |
Iceland |
7.8.2007 (2) |
|
EU/1/97/054/001/NO, 003/NO-005/NO |
Viracept |
Norway |
27.8.2007 (3) |
(1) Lifting of the suspension 31 October 2007 — Viracept EU/1/97/054/001, 003-005.
(2) Lifting of the suspension 14 November 2007 — Viracept EU/1/97/054/001, 004-005/IS.
(3) Lifting of the suspension 29 October 2007 — Viracept EU/1/97/054/001/NO, 003/NO-005/NO.